Spironolactone Suspension for Deep Dermal Pilosebaceous Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing drug delivery systems struggle to penetrate deep into the dermis to target the pilosebaceous unit effectively, as they are hindered by the stratum corneum and upper capillary plexus, necessitating a novel approach to bypass these barriers.
Innovation Solution
Pharmaceutical compositions comprising small particles of spironolactone suspended in water, with specific particle size distributions, are developed to target the pilosebaceous unit, achieving dermal penetration of at least 1 mm, preferably 2 or 3 mm.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of stationary object
If traditional drug delivery systems are used, then the stratum corneum barrier is maintained, but deep dermal penetration to the pilosebaceous unit is insufficient
Solution Approach 1:
The patent changes the physical-chemical parameters of the drug formulation by using small particles of spironolactone (D90 < 6 μm, D50 < 2.7 μm, D10 < 1.2 μm) suspended in water with specific surfactants (dioctyl sodium sulfosuccinate) and polymers (hydroxyl propyl cellulose). These parameter changes enable the formulation to bypass the stratum corneum barrier and achieve deep dermal penetration of at least 1 mm to the pilosebaceous unit.
2Length of stationary object
If transdermal delivery is used, then first-pass metabolism is circumvented, but deep dermal penetration to 1-3 mm depth is difficult to achieve
Solution Approach 1:
The patent applies local quality by creating a formulation with specific particle size distribution (D90 < 6 μm, D50 < 2.7 μm, D10 < 1.2 μm) and composition (spironolactone, water, dioctyl sodium sulfosuccinate, hydroxyl propyl cellulose) that is optimized for deep dermal penetration. This localized optimization of formulation properties enables reliable delivery to the pilosebaceous unit at depths of 1-3 mm, achieving therapeutic efficacy at the target site while maintaining the advantages of transdermal delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions enable effective delivery of spironolactone to the pilosebaceous unit, addressing the need for deeper dermal penetration and providing therapeutic benefits for conditions like acne and alopecia.
Implementation Method 1
pharmaceutical compositions comprising small particles of spironolactone suspended in water
Implementation Method 2
The pharmaceutical compositions can be targeted to the pilosebaceous unit after topical administration... achieving dermal penetration of at least 1 mm, preferably 2 or 3 mm
Data Source
AI summary
Pharmaceutical compositions for the topical administration of spironolactone to the pilosebaceous unit and methods for administering the same. The pharmaceutical compositions comprise aqueous suspensions of submicron particles of spironolactone in water.